Literature DB >> 16081987

Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay.

Florence Damond1, Gilles Collin, Diane Descamps, Sophie Matheron, Sophie Pueyo, Audrey Taieb, Pauline Campa, Antoine Benard, Geneviève Chêne, Francoise Brun-Vezinet.   

Abstract

We developed a new assay for human immunodeficiency virus type 2 plasma RNA quantification based on a previous format. The new version performed significantly better than the original regarding the detection of subtype B, allowing the detection of 14 out of 36 plasma RNAs in the subtype B-infected patients not detected with the original version.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16081987      PMCID： PMC1233899          DOI： 10.1128/JCM.43.8.4234-4236.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  HIV-1 subtypes and plasma RNA quantification.

Authors:  F Damond; C Apetrei; D Descamps; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

2.  Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa.

Authors:  K Ariyoshi; S Jaffar; A S Alabi; N Berry; M Schim van der Loeff; S Sabally; P T N'Gom; T Corrah; R Tedder; H Whittle
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

3.  Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.

Authors:  F Damond; C Apetrei; D L Robertson; S Souquière; A Leprêtre; S Matheron; J C Plantier; F Brun-Vézinet; F Simon
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

4.  Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.

Authors:  Geoffrey S Gottlieb; Papa Salif Sow; Stephen E Hawes; Ibra Ndoye; Mary Redman; Awa M Coll-Seck; Mame A Faye-Niang; Aissatou Diop; Jane M Kuypers; Cathy W Critchlow; Richard Respess; James I Mullins; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

5.  Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.

Authors:  Sophie Matheron; Sophie Pueyo; Florence Damond; François Simon; Annie Leprêtre; Pauline Campa; Roger Salamon; Genevieve Chêne; Françoise Brun-Vezinet
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

6.  Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification.

Authors:  Florence Damond; Michael Worobey; Pauline Campa; Isabelle Farfara; Gilles Colin; Sophie Matheron; Françoise Brun-Vézinet; David L Robertson; François Simon
Journal:  AIDS Res Hum Retroviruses       Date:  2004-06       Impact factor: 2.205

7.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

Authors:  F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Authors:  Florence Damond; Marie Gueudin; Sophie Pueyo; Isabelle Farfara; David L Robertson; Diane Descamps; Geneviève Chène; Sophie Matheron; Pauline Campa; Françoise Brun-Vézinet; François Simon
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Authors:  R Marlink; P Kanki; I Thior; K Travers; G Eisen; T Siby; I Traore; C C Hsieh; M C Dia; E H Gueye
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

10.  Slower heterosexual spread of HIV-2 than HIV-1.

Authors:  P J Kanki; K U Travers; S MBoup; C C Hsieh; R G Marlink; A Gueye-NDiaye; T Siby; I Thior; M Hernandez-Avila; J L Sankalé
Journal:  Lancet       Date:  1994-04-16       Impact factor: 79.321
View more
  12 in total

1.  Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.

Authors:  Charlotte Charpentier; Bénédicte Roquebert; Olivier Delelis; Lucile Larrouy; Sophie Matheron; Roland Tubiana; Marina Karmochkine; Xavier Duval; Geneviève Chêne; Alexandre Storto; Gilles Collin; Antoine Bénard; Florence Damond; Jean-François Mouscadet; Françoise Brun-Vézinet; Diane Descamps
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.

Authors:  Benoit Visseaux; Charlotte Charpentier; Margarita Hurtado-Nedelec; Alexandre Storto; Romain Antoine; Gilles Peytavin; Florence Damond; Sophie Matheron; Françoise Brun-Vézinet; Diane Descamps
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.

Authors:  F Damond; A Benard; Claudia Balotta; Jürg Böni; Matthew Cotten; Vitor Duque; Bridget Ferns; Jeremy Garson; Perpetua Gomes; Fátima Gonçalves; Geoffrey Gottlieb; Bernd Kupfer; Jean Ruelle; Berta Rodes; Vicente Soriano; Mark Wainberg; Audrey Taieb; Sophie Matheron; Genevieve Chene; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

4.  New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Authors:  Mélanie Bertine; Marie Gueudin; Adeline Mélard; Florence Damond; Diane Descamps; Sophie Matheron; Fidéline Collin; Christine Rouzioux; Jean-Christophe Plantier; Véronique Avettand-Fenoel
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

5.  Nano-optofluidic detection of single viruses and nanoparticles.

Authors:  Anirban Mitra; Bradley Deutsch; Filipp Ignatovich; Carrie Dykes; Lukas Novotny
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

6.  New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.

Authors:  Véronique Avettand-Fenoel; Florence Damond; Marie Gueudin; Sophie Matheron; Adeline Mélard; Gilles Collin; Diane Descamps; Marie-Laure Chaix; Christine Rouzioux; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

7.  Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.

Authors:  Maud Salmona; Severine Delarue; Constance Delaugerre; François Simon; Sarah Maylin
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

8.  Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.

Authors:  Ming Chang; Geoffrey S Gottlieb; Joan A Dragavon; Stephen L Cherne; Donna L Kenney; Stephen E Hawes; Robert A Smith; Nancy B Kiviat; Papa Salif Sow; Robert W Coombs
Journal:  J Clin Virol       Date:  2012-07-24       Impact factor: 3.168

9.  Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.

Authors:  Florence Damond; Antoine Benard; Jean Ruelle; Abraham Alabi; Bernd Kupfer; Perpetua Gomes; Berta Rodes; Jan Albert; Jürg Böni; Jeremy Garson; Bridget Ferns; Sophie Matheron; Geneviève Chene; Françoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

10.  Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.

Authors:  Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun-Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.